Anti-LPA Therapeutic Antibody scFv Fragment (LT3015 [B7(LT3000, Lpathomab)])
The high-affinity, specific monoclonal antibodies to LPA, one of which is also called Lpathpmab. The target of the antibody lysophosphatidic acid is a bioactive lipid mediating multiple cellular response, and it's involved in the establishment and progression of cancer by providing a pro-growth tumor microenvironment and promoting angiogenesis. By specifically react to LPA, the anti-LPA antbodies can be used in the treatment and prevention of malignancies, angiogenesis, and fibrosis-related disorders.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-0340CL-S(P) |
| Pricing | Inquiry |
| Type | Humanized Antibody |
| Host | Human |
| Target | LPA (lysophosphatidic acid) |